“mRNA Therapeutics” — FilingIndex Search

Filter

46 of 3,901

Sort

PFEPFIZER INC🔥

Healthcare · Pharmaceuticals

$149.38B-1.2%

P/E 19.8·P/S 2.4·Mgn 11.9%·ROE 9.0%·FCF 6.1%

F 6

Red 8-K

ALNYALNYLAM PHARMACEUTICALS, INC.⚡

Healthcare · Pharmaceuticals

$37.76B+2.6%

P/E 120.4·P/S 10.2·Mgn 8.4%·ROE 39.8%·FCF 1.2%

F 6

Red 8-K

AAGILENT TECHNOLOGIES, INC.🔥

Healthcare · Diagnostics & Tools

$36.67B0.0%

P/E 25.9·P/S 5.1·Mgn 19.6%·ROE 19.3%·FCF 3.1%

F 5

Red 8-K

WATWATERS CORP /DE/⚡

Healthcare · Diagnostics & Tools

$34.91B+1.7%

P/E 54.3·P/S 11.0·Mgn 20.3%·ROE 25.1%·FCF 1.5%

F 4

ROIVRoivant Sciences Ltd.

Healthcare · Pharmaceuticals

$21.61B+1.9%

P/E —·P/S 2615.8·Mgn -4817.3%·ROE -6.6%·FCF -3.5%

—

MRNAModerna, Inc.🔥

Healthcare · Biotechnology

$19.80B+0.5%

P/E —·P/S 8.9·Mgn -143.6%·ROE -32.6%·FCF -10.4%

F 3

IONSIONIS PHARMACEUTICALS INC

Healthcare · Pharmaceuticals

$12.11B-1.7%

P/E —·P/S 11.4·Mgn -30.9%·ROE -78.0%·FCF -2.6%

F 3

Red 8-K

MDGLMADRIGAL PHARMACEUTICALS, INC.

Healthcare · Pharmaceuticals

$11.08B+1.8%

P/E —·P/S 9.8·Mgn -27.3%·ROE -47.8%·FCF -1.7%

—

Red 8-K

ARWRARROWHEAD PHARMACEUTICALS, INC.

Healthcare · Pharmaceuticals

$10.50B+1.3%

P/E —·P/S 16.9·Mgn -43.7%·ROE -0.3%·FCF 1.5%

—

Red 8-K

DCIDONALDSON Co INC

Industrials · Machinery

$10.01B+1.6%

P/E 22.8·P/S 2.6·Mgn 11.5%·ROE 25.2%·FCF 3.4%

F 6

CRSPCRISPR Therapeutics AG⚡

Healthcare · Biotechnology

$4.90B-3.2%

P/E —·P/S 1195.3·Mgn -13856.5%·ROE -30.3%·FCF -7.1%

—

Dilut.Red 8-K

TWSTTwist Bioscience Corp

Healthcare · Biotechnology

$4.74B+4.6%

P/E —·P/S 11.6·Mgn -19.8%·ROE -16.4%·FCF -1.6%

F 4

STVNStevanato Group S.p.A.

Healthcare · Medical Devices

$4.66B+4.1%

P/E 28.1·P/S 3.8·Mgn 13.4%·ROE 9.4%·FCF 0.5%

—

TARSTarsus Pharmaceuticals, Inc.

Healthcare · Biotechnology

$2.67B+2.7%

P/E —·P/S 5.9·Mgn -14.7%·ROE -19.3%·FCF -0.8%

—

AMLXAmylyx Pharmaceuticals, Inc.

Healthcare · Pharmaceuticals

$1.62B-4.0%

P/E —·P/S —·Mgn —·ROE -47.4%·FCF -7.6%

—

SRPTSarepta Therapeutics, Inc.

Healthcare · Pharmaceuticals

$1.62B+5.6%

P/E —·P/S 0.7·Mgn -32.5%·ROE -62.5%·FCF -19.0%

—

Red 8-K

PGENPRECIGEN, INC.

Healthcare · Pharmaceuticals

$1.59B-3.7%

P/E —·P/S 50.2·Mgn -647.0%·ROE -1198.6%·FCF -5.7%

—

13DRed 8-K

CAPRCAPRICOR THERAPEUTICS, INC.

Healthcare · Pharmaceuticals

$1.49B+1.2%

P/E —·P/S 67.1·Mgn -181.7%·ROE -34.4%·FCF -4.9%

—

NVAXNOVAVAX INC

Healthcare · Biotechnology

$1.46B+0.6%

P/E —·P/S 2.4·Mgn -14.7%·ROE —·FCF —

F 6

13D

WVEWave Life Sciences Ltd.

Healthcare · Pharmaceuticals

$1.13B+2.3%

P/E —·P/S 15.7·Mgn -255.7%·ROE -39.4%·FCF -16.7%

—

13D

MGTXMeiraGTx Holdings plc

Healthcare · Biotechnology

$888M+7.7%

P/E —·P/S 11.1·Mgn -151.1%·ROE —·FCF -5.7%

—

13D

ABUSArbutus Biopharma Corp

Healthcare · Pharmaceuticals

$842M+2.6%

P/E 5.2·P/S 4.4·Mgn 84.0%·ROE -43.7%·FCF -4.7%

—

13DRed 8-K

CTMXCytomX Therapeutics, Inc.

Healthcare · Pharmaceuticals

$655M+0.3%

P/E —·P/S 18.4·Mgn -166.4%·ROE -17.5%·FCF -11.6%

—

Red 8-K

CADLCandel Therapeutics, Inc.

Healthcare · Biotechnology

$627M-0.6%

P/E —·P/S —·Mgn —·ROE -73.5%·FCF —

—

13DRed 8-K

VALNValneva SE

Healthcare · Biotechnology

$508M+1.2%

P/E —·P/S 2.9·Mgn -66.0%·ROE -108.5%·FCF -12.9%

—

13D

PRMEPrime Medicine, Inc.

Healthcare · Biotechnology

$501M-0.8%

P/E —·P/S 124.2·Mgn -4917.6%·ROE -166.4%·FCF -33.3%

—

Red 8-K

STTKShattuck Labs, Inc.

Healthcare · Pharmaceuticals

$472M+1.3%

P/E —·P/S 471.8·Mgn -4987.4%·ROE -59.2%·FCF -8.5%

—

13DRed 8-K

NGNENeurogene Inc.

Healthcare · Pharmaceuticals

$460M-2.6%

P/E —·P/S —·Mgn —·ROE -34.1%·FCF -17.0%

—

Red 8-K

BNTCBenitec Biopharma Inc.

Healthcare · Pharmaceuticals

$384M+5.3%

P/E —·P/S —·Mgn —·ROE -39.0%·FCF —

—

Red 8-K

AVIRAtea Pharmaceuticals, Inc.

Healthcare · Pharmaceuticals

$359M+0.9%

P/E —·P/S —·Mgn —·ROE -57.5%·FCF —

—

UPBUpstream Bio, Inc.

Healthcare · Pharmaceuticals

$332M-0.1%

P/E —·P/S 116.3·Mgn -5026.0%·ROE -42.2%·FCF -40.2%

—

ABEOABEONA THERAPEUTICS INC.

Healthcare · Pharmaceuticals

$315M+9.2%

P/E —·P/S —·Mgn —·ROE 44.7%·FCF -26.7%

—

Red 8-K

RNACCartesian Therapeutics, Inc.

Healthcare · Pharmaceuticals

$279M+8.1%

P/E —·P/S 99.9·Mgn -4658.6%·ROE —·FCF -28.4%

—

13DDilut.Red 8-K

TRDAEntrada Therapeutics, Inc.

Healthcare · Pharmaceuticals

$251M-4.5%

P/E —·P/S 43.7·Mgn -2895.1%·ROE -47.0%·FCF -51.7%

—

Red 8-K

AVXLANAVEX LIFE SCIENCES CORP.

Healthcare · Biotechnology

$232M-0.4%

P/E —·P/S 49.5·Mgn -991.4%·ROE -48.9%·FCF —

—

Red 8-K

CDXSCODEXIS, INC.

Materials · Chemicals

$218M-3.0%

P/E —·P/S 2.8·Mgn -41.0%·ROE -87.0%·FCF -10.9%

F 4

Red 8-K

CAMPCamp4 Therapeutics Corp

Healthcare · Pharmaceuticals

$218M-1.6%

P/E —·P/S 55.3·Mgn -2193.7%·ROE -168.5%·FCF -13.7%

—

13DRed 8-K

VYGRVoyager Therapeutics, Inc.

Healthcare · Biotechnology

$211M-2.2%

P/E —·P/S 5.8·Mgn -319.6%·ROE -61.1%·FCF -63.9%

—

Red 8-K

WHWKWhitehawk Therapeutics, Inc.

Healthcare · Pharmaceuticals

$206M+3.9%

P/E —·P/S 28.8·Mgn -288.3%·ROE -15.1%·FCF -47.6%

F 4

13DDilut.

ARCTArcturus Therapeutics Holdings Inc.

Healthcare · Pharmaceuticals

$198M-1.5%

P/E —·P/S 3.6·Mgn -143.8%·ROE -30.7%·FCF -37.6%

—

Red 8-K

PRQRProQR Therapeutics N.V.

Healthcare · Pharmaceuticals

$152M+1.6%

P/E —·P/S 98.3·Mgn -4490.3%·ROE -85.4%·FCF -40.4%

—

13D

HURATuHURA Biosciences, Inc./NV

Healthcare · Pharmaceuticals

$148M+2.2%

P/E —·P/S —·Mgn —·ROE -143.6%·FCF -18.8%

—

Dilut.Red 8-K

MXCTMAXCYTE, INC.

Healthcare · Biotechnology

$120M-0.8%

P/E —·P/S 3.6·Mgn -135.1%·ROE -26.0%·FCF -30.2%

F 2

13DRed 8-K

CRDLCardiol Therapeutics Inc.

Healthcare · Biotechnology

$119M+2.9%

P/E —·P/S —·Mgn —·ROE -41.5%·FCF -13.9%

—

ANVSAnnovis Bio, Inc.

Healthcare · Pharmaceuticals

$76M0.0%

P/E —·P/S —·Mgn —·ROE -171.2%·FCF —

—

OSTXOS Therapies Inc

Healthcare · Pharmaceuticals

$76M-15.2%

P/E —·P/S —·Mgn —·ROE —·FCF —

—

Dilut.

Filings · filterAll 10-K 10-Q 8-K S-1 DEF 14A SC 13D

Filings

40 shown

UGROurban-gro, Inc.

S-1

IPO registration — a company preparing to go public.

Jun 30, 2026·22h ago

CGCTUCartesian Growth Corp III

S-1

IPO registration — a company preparing to go public.

Companies above the $50M market cap · $1 pricefloor; SPAC/shells hidden by default. Fundamentals & prices via Polygon · signals from SEC EDGAR — verify on SEC.gov. Filings current to Jun 30 · prices to Jun 30.